Pharmaceuticals News

Bilan semestriel du contrat de liquidité avec Invest Securities Half-Year Report on Liquidity Contract with Invest Securities

NANTES, France, le 8 juillet 2026, 18h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) – Au titre du contrat de liquidité confié par OSE Immunotherapeutics à Invest Securities,...

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 08 juillet 2026 – GENFIT (Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients...

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with...

90.5% interim disease control rate (DCR) observed with combination therapy Initial Part C efficacy observations align with previously reported THIO-101 clinical activity despite a more heavily...

Vaccinex reports new biomarker research and plans for Phase 2 randomized clinical trial of pepinemab in Alzheimer's Disease at the AAIC in July

Polomar Health Services (OTCQB: PMHS) names George Hornig Executive Chairman and George Caruolo Lead Independent Director, adding three board members.

Boca Raton, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (“NOMAD” or the “Company”) (Nasdaq: NMAD), through its wholly owned subsidiary, Nomad Transportable Power Systems...

60 Degrees Pharma (Nasdaq: SXTP) secures exclusive option to develop castanospermine for tick-borne diseases, expanding its infectious disease pipeline.

GeneCentric launches ExpressCT Rewind™ service offering to unlock gene expression insights from existing liquid biopsy DNA sequencing.